About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Efficacy and Safety of SPARC0921 in Subjects With Spasticity

Efficacy and Safety of SPARC0921 in Subjects With Spasticity

NCT01457352·73 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Sun Pharma Advanced Research Company Limited

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Men and women age 18 years and older
Able and willing to comply with the protocol, including availability for a scheduled clinic visits
Willingness and giving of written informed consent

You may not be if

In relapse or history of unstable course over the prior 30 days prior to the Screening Visit
Concomitant neurologic conditions causing spasticity
Has received an investigational drug or device within 30 days that would interfere with the study goals prior to the Screening Visit
Unable to comply with study procedures in the opinion of the investigator

The record

StatusCompleted

PhasePhase 3

Taking part392

StartedNov 2012

UpdatedJun 18, 2019

Conditions

Where73

SPARC site 6
Gilbert, Arizona, United States
SPARC Site 40
Phoenix, Arizona, United States
SPARC Site 36
Costa Mesa, California, United States